Genovis AB (publ.)

Genovis AB (publ.)verified

GENO.ST

Price:

$19.36

Market Cap:

$1.27B

Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, as well as for generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; and GingisKHAN, a cysteine protease that digests human IgG1 at a specific site above the hinge. In addition, the company offers GingisREX, a cysteine protease that specifica...[Read more]

Industry

Biotechnology

IPO Date

2008-06-02

Stock Exchange

STO

Ticker

GENO.ST

The Current Ratio as of December 2025 (TTM) for Genovis AB (publ.) (GENO.ST) is 10.78

According to Genovis AB (publ.)’s latest financial reports and current stock price. The company's current Current Ratio is 10.78. This represents a change of 10.18% compared to the average of 9.78 of the last 4 quarters.

Genovis AB (publ.) (GENO.ST) Historical Current Ratio (quarterly & annually)

How has GENO.ST Current Ratio performed in the past?

The mean historical Current Ratio of Genovis AB (publ.) over the last ten years is 4.33. The current 10.78 Current Ratio has changed 24.79% with respect to the historical average. Over the past ten years (40 quarters), GENO.ST's Current Ratio was at its highest in in the June 2025 quarter at 12.69. The Current Ratio was at its lowest in in the March 2016 quarter at 0.97.

Quarterly (TTM)
Annual

Average

4.33

Median

3.78

Minimum

1.36

Maximum

7.49

Genovis AB (publ.) (GENO.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Genovis AB (publ.) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 82.10%

Maximum Annual Current Ratio = 7.49

Minimum Annual Increase = -35.43%

Minimum Annual Current Ratio = 1.36

Quarterly (TTM)
Annual
YearCurrent RatioChange
20247.38-1.46%
20237.4926.12%
20225.9432.33%
20214.49-14.39%
20205.2470.93%
20193.07-0.37%
20183.0811.83%
20172.7511.24%
20162.4882.10%
20151.36-35.43%

Genovis AB (publ.) (GENO.ST) Average Current Ratio

How has GENO.ST Current Ratio performed in the past?

The current Current Ratio of Genovis AB (publ.) (GENO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

6.94

5-year avg

6.11

10-year avg

4.33

Genovis AB (publ.) (GENO.ST) Current Ratio vs. Peers

How is GENO.ST’s Current Ratio compared to its peers?

Genovis AB (publ.)’s Current Ratio is greater than Diamyd Medical AB (publ) (10.64), greater than Oncopeptides AB (publ) (3.42), greater than SynAct Pharma AB (3.28), greater than BICO Group AB (publ) (1.06), greater than Stille AB (3.24), greater than OssDsign AB (publ) (10.37), greater than Paxman AB (publ) (4.68), greater than I-Tech AB (7.67), greater than Xspray Pharma AB (publ) (6.72), greater than Cantargia AB (publ) (5.82),

Build a custom stock screener for Genovis AB (publ.) (GENO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genovis AB (publ.) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genovis AB (publ.) (GENO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genovis AB (publ.) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Genovis AB (publ.)'s Current Ratio?

How is the Current Ratio calculated for Genovis AB (publ.) (GENO.ST)?

What is the highest Current Ratio for Genovis AB (publ.) (GENO.ST)?

What is the 3-year average Current Ratio for Genovis AB (publ.) (GENO.ST)?

What is the 5-year average Current Ratio for Genovis AB (publ.) (GENO.ST)?

How does the current Current Ratio for Genovis AB (publ.) (GENO.ST) compare to its historical average?